estim
world
popul
infect
mycobacterium
tuberculosi
million
new
case
million
death
annual
raviglion
epidemiolog
observ
indic
latent
tuberculosi
tb
infect
progress
activ
tb
lifetim
whether
person
develop
tb
depend
interact
sever
line
evid
indic
suscept
tb
determin
partli
host
genet
factor
possibl
influenc
environment
factor
well
schurr
mutat
gene
signal
pathway
result
increas
suscept
tb
sever
suscept
gene
tlr
gene
also
identifi
schurr
austin
et
al
mycobacterium
tuberculosi
primarili
infect
macrophag
insid
cell
bacteria
modul
endosomalphagosom
matur
pathway
block
fusion
mycobacteri
phagosom
lysosom
avoid
bactericid
mechan
host
cell
houben
et
al
recent
murin
thymoma
viral
oncogen
homolog
serinethreonin
kinas
also
known
protein
kinas
b
pkb
identifi
key
kinas
involv
control
intracellular
growth
tuberculosi
regul
host
cell
signal
pathway
kuijl
et
al
specif
small
molecul
inhibitor
could
significantli
inhibit
prolifer
tuberculosi
strain
resist
strain
primari
human
macrophag
without
induc
apoptosi
host
cell
kuijl
et
al
specif
knockdown
akt
express
prevent
intracellular
growth
mycobacterium
smegmati
human
macrophag
previou
studi
found
activ
akt
prevent
phagosom
matur
hernandez
et
al
inhibit
induc
phagosom
matur
phagolysosom
result
kill
intracellular
bacteria
kuijl
et
al
therefor
inhibitor
potenti
use
antibiot
treatment
tb
especi
tb
clear
whether
polymorph
gene
affect
suscept
tb
studi
investig
two
singl
nucleotid
polymorph
snp
gene
relat
haplotyp
sampl
chines
popul
found
associ
suscept
pulmonari
tb
total
chines
patient
han
ethnic
group
men
women
mean
age
year
pulmonari
tb
enrol
studi
inpati
institut
tuberculosi
hospit
beij
china
diagnos
pulmonari
tb
base
result
acid
fast
stain
sputum
smear
bacteri
cultur
mycobacteria
chest
examin
well
clinic
symptom
respons
standard
chemotherapi
regimen
total
peopl
men
women
mean
age
year
underw
regular
health
enrol
control
criteria
select
control
follow
peopl
chines
han
ethnic
group
select
age
year
malefemal
ratio
similar
tb
patient
group
peopl
obes
bodi
mass
index
bmi
kg
exclud
control
control
individu
select
randomli
control
individu
normal
chest
appear
histori
tb
patient
control
hiv
neg
none
known
present
immunosuppress
condit
studi
approv
ethic
committe
hospit
inform
consent
obtain
patient
whole
blood
treat
ethylenediaminetetraacet
acid
prevent
coagul
dna
isol
whole
blood
blood
dna
extract
kit
accord
protocol
provid
manufactur
tiangen
china
genom
dna
dissolv
te
buffer
store
need
assess
two
snp
studi
locat
posit
intron
genom
sequenc
genbank
access
design
snp
fig
locat
site
sequenc
design
snp
fig
singl
nucleotid
polymorph
genotyp
perform
polymeras
chain
reaction
amplif
pcr
fragment
length
polymorph
assay
follow
protocol
provid
dr
nadao
iwata
fujita
health
univers
school
medicin
nagoya
japan
ikeda
et
al
modif
pcr
amplif
procedur
genotyp
nest
pcr
appli
inner
primer
set
outer
primer
set
size
pcr
product
amplifi
inner
primer
bp
primer
set
snp
result
pcr
product
bp
long
restrict
enzym
haeiii
use
genotyp
haplotyp
analys
unphas
program
base
likelihood
ratio
test
model
associ
studi
dudbridg
test
test
use
evalu
differ
demograph
variabl
statist
packag
spss
window
spss
inc
chicago
il
usa
statist
correct
p
valu
multipl
test
perform
bonferroni
correct
odd
ratio
p
valu
calcul
uncondit
logist
regress
statist
packag
spss
equilibrium
assess
haploview
program
barrett
et
al
associ
analysi
includ
genotyp
analysi
allel
frequenc
evalu
unphas
program
dudbridg
haplotyp
allelewis
analysi
permut
analysi
use
perform
permut
analysi
signific
level
statist
test
studi
includ
tb
patient
men
women
mean
age
year
ethnic
match
control
subject
men
women
mean
age
year
chines
han
ethnic
group
demograph
characterist
patient
tb
healthi
control
individu
given
tabl
occurr
pulmonari
tb
significantli
associ
age
p
gender
p
exposur
tb
patient
p
bmi
p
popul
studi
snp
select
associ
studi
two
reason
fig
first
previou
studi
demonstr
haplotyp
associ
differ
express
level
protein
ccgg
major
haplotyp
significantli
higher
express
lower
apoptosi
cell
minor
ttaa
haplotyp
harri
et
al
secondli
locat
middl
part
genom
sequenc
five
exon
distanc
bp
two
snp
therefor
polymorph
might
relat
function
chang
cell
genotyp
frequenc
two
snp
equilibrium
analysi
snp
show
patient
pulmonari
tb
significantli
lower
cc
homozyg
genotyp
p
higher
ct
heterozyg
genotyp
p
compar
ethnic
match
control
tabl
minor
tt
homozyg
genotyp
one
person
group
signific
could
determin
allel
frequenc
c
also
demonstr
signific
differ
case
control
group
p
tabl
howev
differ
allel
frequenc
statist
signific
p
valu
adjust
bonferroni
correct
result
indic
cc
homozyg
genotyp
neg
associ
pulmonari
tb
snp
synonym
polymorph
locat
exon
genom
sequenc
although
gg
homozyg
genotyp
much
lower
patient
pulmonari
tb
control
vs
differ
statist
signific
p
tabl
contrast
patient
group
significantli
higher
ga
heterozyg
genotyp
control
vs
p
overal
g
allel
frequenc
similar
two
group
p
tabl
result
mix
support
associ
snp
pulmonari
tb
next
analys
frequenc
haplotyp
unphas
program
dudbridg
fig
four
differ
haplotyp
major
minor
haplotyp
similar
frequenc
among
case
control
p
tabl
minor
haplotyp
significantli
higher
frequenc
patient
control
p
tabl
indic
posit
associ
pulmonari
tb
perform
logist
regress
analysi
snp
tb
patient
clinic
characterist
includ
age
sputum
smearcultur
result
lung
caviti
tb
ct
heterozyg
genotyp
snp
site
neg
associ
tb
patient
group
although
significantli
ci
serinetheronin
kinas
akt
central
node
cell
signal
cytokin
cellular
stimuli
function
downstream
phosphatidylinositol
man
cantley
activ
phosphoryl
gener
recruit
akt
cell
membran
result
phosphoryl
activ
akt
initi
downstream
signal
cascad
three
isoform
akt
also
known
encod
separ
gene
target
isoform
mice
reveal
specif
redund
function
recent
studi
identifi
signal
pathway
critic
regul
replic
number
virus
includ
influenza
viru
parainfluenza
viru
myxoma
viru
sever
acut
respiratori
hepat
b
viru
mizutani
et
al
wang
et
al
guo
et
al
shin
et
al
sun
et
al
suppress
activ
specif
small
molecular
inhibitor
result
reduct
influenza
viru
yield
human
lung
carcinoma
cell
shin
et
al
akt
pathway
shown
key
restrict
determin
permiss
human
cancer
cell
myxoma
viru
wang
et
al
inhibitor
protein
kinas
jnk
prevent
establish
persist
infect
vero
cell
mizutani
et
al
akt
signal
pathway
also
play
import
role
invas
replic
bacteria
group
b
streptococcu
requir
signal
pathway
invas
epitheli
cell
burnham
et
al
inhibitor
could
significantli
reduc
growth
salmonella
typhimurium
tuberculosi
host
cell
induc
phagosom
matur
phagolysosom
kuijl
et
al
might
use
antibiot
treatment
infect
numer
snp
identifi
human
six
design
mostli
studi
report
associ
sever
diseas
parkinson
diseas
xiromerisi
et
al
schizophrenia
ikeda
et
al
schwab
et
al
biopolar
pedigre
yoyota
et
al
recent
somat
mutat
identifi
mutat
lead
patholog
local
plasma
membran
activ
implic
human
breast
colorect
ovarian
cancer
carpten
et
al
knowledg
report
relationship
human
polymorph
suscept
tb
studi
found
associ
snp
haplotyp
pulmonari
tb
sinc
synonym
snp
possibl
polymorph
might
involv
regul
express
studi
previou
studi
prove
snp
significantli
alter
express
activ
harri
et
al
carpten
et
al
possibl
snp
locu
might
influenc
control
tuberculosi
replic
human
ultim
develop
activ
diseas
haplotyp
result
base
comparison
haplotyp
frequenc
sampl
high
percentag
heterozyg
genotyp
patient
control
differ
frequenc
may
directli
relat
express
level
cell
expect
interpret
result
cautiou
conclus
two
snp
gene
relat
haplotyp
investig
sampl
chines
han
ethnic
popul
snp
haplotyp
found
associ
suscept
pulmonari
tb
might
good
candid
genet
marker
risk
evalu
tb
author
commerci
associ
might
pose
conflict
interest
